Atlas Trials

Comparison of Effect & Safety of Clopidogrel Napadisilate With Clopidogrel Bisulfate in Coronary Artery Disease Patients

Clinical trial NCT01830491 · COMPLETED

Trial details

NCT number
NCT01830491
Sponsor
Hanmi Pharmaceutical Company Limited
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Coronary Artery Disease (CAD)
Start date
2009-03-01
Primary completion
2009-08-01
Enrollment
162

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.